Tectonic Therapeutic, Ebitda Over Time
| TECX Stock | 49.78 0.62 1.26% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Tectonic Therapeutic, Performance and Tectonic Therapeutic, Correlation. Tectonic |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tectonic Therapeutic,. If investors know Tectonic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tectonic Therapeutic, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.07) |
The market value of Tectonic Therapeutic, is measured differently than its book value, which is the value of Tectonic that is recorded on the company's balance sheet. Investors also form their own opinion of Tectonic Therapeutic,'s value that differs from its market value or its book value, called intrinsic value, which is Tectonic Therapeutic,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tectonic Therapeutic,'s market value can be influenced by many factors that don't directly affect Tectonic Therapeutic,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tectonic Therapeutic,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Tectonic Therapeutic, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tectonic Therapeutic,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Ebitda Analysis
Compare Tectonic Therapeutic, and related stocks such as Genfit, Vita Coco, and Boston Beer Ebitda Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GNFT | 2.6 M | (6.6 M) | (6.8 M) | (9.7 M) | (16.6 M) | (16.6 M) | (32.8 M) | (54.6 M) | (67.1 M) | (47.2 M) | (91.1 M) | 34.9 M | (23.6 M) | (22.2 M) | (23.3 M) |
| COCO | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 46.5 M | 26.7 M | 14.1 M | 58.6 M | 35.7 M |
| SAM | 9.9 M | 83 M | 116.1 M | 142.1 M | 185.3 M | 199.6 M | 186.7 M | 171.8 M | 169.2 M | 203 M | 317.4 M | 87.1 M | 242.7 M | 210 M | 106.4 M |
| WVVI | 200 K | 2.3 M | 3.1 M | 3.3 M | 4.3 M | 4.8 M | 5.7 M | 5.5 M | 6.1 M | 5.7 M | 7.1 M | 6.2 M | 1.9 M | 2.3 M | 2.9 M |
| ARDX | (7.2 M) | (7.2 M) | (7.2 M) | 1.2 M | (1.3 M) | (28.6 M) | (111.6 M) | (62.5 M) | (87.8 M) | (88.9 M) | (85.2 M) | (150.9 M) | (61 M) | (55.4 M) | (58.1 M) |
| CCU | 74.6 B | 191.8 B | 183.1 B | 190.7 B | 183.8 B | 199.3 B | 198.3 B | 228.5 B | 470.2 B | 208.7 B | 288.8 B | 454 B | 332.4 B | 344.1 B | 208.2 B |
| LPCN | (5.2 K) | (5.2 K) | (76.7 K) | (6.8 M) | (20.5 M) | (18.4 M) | (17.7 M) | (21.2 M) | (11.3 M) | (13.1 M) | (18 M) | (430.5 K) | (10.7 M) | (16.3 M) | (17.1 M) |
| TCRX | (13.7 M) | (13.7 M) | (13.7 M) | (13.7 M) | (13.7 M) | (13.7 M) | (13.7 M) | (13.7 M) | (13.7 M) | (13.7 M) | (25 M) | (45.3 M) | (59.9 M) | (80.1 M) | (76.1 M) |
Tectonic Therapeutic, and related stocks such as Genfit, Vita Coco, and Boston Beer Ebitda description
My Equities
My Current Equities and Potential Positions
| Tectonic Therapeutic, | TECX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
null 49.78
Additional Tools for Tectonic Stock Analysis
When running Tectonic Therapeutic,'s price analysis, check to measure Tectonic Therapeutic,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tectonic Therapeutic, is operating at the current time. Most of Tectonic Therapeutic,'s value examination focuses on studying past and present price action to predict the probability of Tectonic Therapeutic,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tectonic Therapeutic,'s price. Additionally, you may evaluate how the addition of Tectonic Therapeutic, to your portfolios can decrease your overall portfolio volatility.